MARK L HARRISON
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology MCALLEN, TX NPI 1417954124
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology TX Bayer HealthCare Pharmaceuticals Inc. All categories
General Payments — all program years on this page
$3,501.34
- Category: General Payments
- Program years: PY2018–2024
- Record count: 218
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $588.28 across 34 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $588.28 | 34 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $133.70 | 9 |
| SOBI, INC | $54.50 | 3 |
| Janssen Biotech, Inc. | $48.45 | 2 |
| Daiichi Sankyo Inc. | $42.56 | 2 |
| TAIHO ONCOLOGY, INC. | $41.13 | 2 |
| Genentech USA, Inc. | $38.81 | 2 |
| Fennec Pharmaceuticals, Inc. | $26.13 | 2 |
| SpringWorks Therapeutics, Inc. | $22.73 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.09 | 1 |
| GENZYME CORPORATION | $19.93 | 1 |
| Genmab U.S., Inc. | $19.09 | 1 |
| Merck Sharp & Dohme Corporation | $18.94 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.39 | 1 |
| BeiGene USA, Inc. | $15.66 | 1 |
| Sirtex Medical Inc | $13.87 | 1 |
| GlaxoSmithKline, LLC. | $13.69 | 1 |
| TerSera Therapeutics LLC | $13.37 | 1 |
| Ipsen Biopharmaceuticals, Inc | $13.16 | 1 |
| Regeneron Healthcare Solutions, Inc. | $13.08 | 1 |
By program year
Records — PY2024 (34)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.